BRCA1 and ovarian cancer: Consistent with this idea, we showed that ovarian cancer tissue with a hypermethylated BRCA1 promoter displayed decreased expression of BRCA1 in comparison with adjacent normal tissue (Figure 3Aii and Bi, P < 0.05).